Showing 1 - 9 results of 9 for search 'Bo-Hua Kuang', query time: 0.04s Refine Results
  1. 1
    Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis

    Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis by Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin, Chen Fu

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies

    Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies by Bi-Cheng Wang, Guo-He Lin, Bo-Hua Kuang, Ru-Bo Cao

    Published 2024-06-01
    Get full text
    Article
  3. 3
    The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials

    The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analys... by Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, Guo-He Lin

    Published 2022-01-01
    Get full text
    Article
  4. 4
    The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials.

    The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analys... by Bi-Cheng Wang, Wen-Xuan Zhang, Bo-Hua Kuang, Guo-He Lin

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies

    Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies by Bo-Hua Kuang, Bo-Hua Kuang, Wen-Xuan Zhang, Wen-Xuan Zhang, Guo-He Lin, Chen Fu, Ru-Bo Cao, Ru-Bo Cao, Bi-Cheng Wang, Bi-Cheng Wang

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis

    Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis by Bi-Cheng Wang, Bo-Hua Kuang, Xin-Xiu Liu, Guo-He Lin, Quentin Liu

    Published 2022-07-01
    Get full text
    Article
  7. 7
    Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials

    Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials by Bi-Cheng Wang, Bo-Hua Kuang, Bo-Ya Xiao, Bo-Ya Xiao, Guo-He Lin

    Published 2021-11-01
    Get full text
    Article
  8. 8
    HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19

    HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19 by Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jincun Zhao, Lin Feng

    Published 2023-12-01
    Get full text
    Article
  9. 9
    A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19

    A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19 by Tao Chen, Yu-Xin Lin, Yan Zha, Ying Sun, Jinxiu Tian, Zhiying Yang, Shan-Wen Lin, Fuxun Yu, Zi-Sheng Chen, Bo-Hua Kuang, Jin-Ju Lei, Ying-jie Nie, Yonghao Xu, Dong-Bo Tian, Ying-Zi Li, Bin Yang, Qiang Xu, Li Yang, Nanshan Zhong, Meizhen Zheng, Yimin Li, Jincun Zhao, Xiang-Yan Zhang, Lin Feng

    Published 2021-10-01
    Get full text
    Article

Search Tools: